Dr. Danielle Caefer

Danielle Caefer completed her PhD in Physiology and Neurobiology at the University of Connecticut in the lab of Dr. Daniel Schwartz. Her work during this time focused on characterizing disease associated variants of protein kinases, expanding the number of specificity shifting variants identified, including the first to be associated with neurodevelopmental disease. Her graduate work also focused on using quantitative proteomic and phosphoproteomic methods to elucidate molecular mechanisms of Okur Chung Neurodevelopmental Syndrome (OCNDS) as they related to protein kinase CK2 signaling. Danielle is currently a Postdoctoral Fellow at Brigham and Women’s Hospital and Harvard Medical School. As a member of the Translational Neuroimmunology Center, led by Dr. Tanuja Chitinis, she has gained insight into translational research. Danielle's current projects continue to leverage mass spectrometry based proteomic methods to uncover mechanisms underlying disease onset and driving progression in Multiple Sclerosis patients.